Lexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECH™ Delivery of THC, NSAIDs, Nicotine and Vitamins

The Canadian cannabis industry has made significant strides over the last year and although licensed producers have been in the spotlight, other companies have also benefited from this movement. One company we have been watching is Lexaria Bioscience (OTC: LXRP) which has announced several developments over the last year that have the company well positioned…